Skip to main content
. Author manuscript; available in PMC: 2012 Mar 25.
Published in final edited form as: Eur J Pharmacol. 2011 Jan 23;655(1-3):16–22. doi: 10.1016/j.ejphar.2011.01.014

Fig. 5. No change in C6 cell viability after application of synthetic peptides.

Fig. 5

The cells were incubated with the peptides at 10 μM or 0.5 mM for 6 h or 24 h. Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (n = 10).